Ideaya Biosciences
IDEAYA Biosciences is a clinical-stage precision medicine oncology company headquartered in South San Francisco, California (NASDAQ IDYA), focused on discovering, developing, and commercializing targeted therapeutics for genetically defined cancer patient populations. Its research spans PKC inhibition in uveal melanoma, antibody-drug conjugate and DNA-damage-response combinations, synthetic-lethal MTAP-pathway programs, and KAT6/7 epigenetic inhibition, led by the investigational candidate darovasertib in registrational uveal melanoma trials. The company maintains a corporate and investor-relations web presence and does not currently publish a public developer API.
Ideaya Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.
Ideaya Biosciences’ developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API